ACELYRIN, INC. to Participate in Upcoming Investor Conferences


LOS ANGELES, Aug. 22, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that members of its management team will participate in fireside chats and 1x1 meetings at the following investor conferences:

Visit link:
ACELYRIN, INC. to Participate in Upcoming Investor Conferences

Related Posts